The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Rethinking cancer nanotheranostics
Open accessAbstract
Advances in nanoparticle synthesis and engineering have produced nanoscale agents affording both therapeutic and diagnostic functions that are often referred to by the portmanteau ‘nanotheranostics’. The field is associated with many applications in the clinic, especially in cancer management. These include patient stratification, drug-release monitoring, imaging-guided focal therapy and post-treatment response monitoring. Recent advances in nanotheranostics have expanded this notion and enabled the characterization of individual tumours, the prediction of nanoparticle–tumour interactions, and the creation of tailor-designed nanomedicines for individualized treatment. Some of these applications require breaking the dogma that a nanotheranostic must combine both therapeutic and diagnostic agents within a single, physical entity; instead, it can be a general approach in which diagnosis and therapy are interwoven to solve clinical issues and improve treatment outcomes. In this Review, we describe the evolution and state of the art of cancer nanotheranostics, with an emphasis on clinical impact and translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy
Kunjachan, S., Detappe, A., Kumar, R., Ireland, T. J., Cameron, L., Biancur, D. E., Motto‐Ros, V., Sancey, L., Sridhar, S., Makrigiorgos, G. M., et al. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b03073 · Cited by 163
RetractedSignatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
The Path to Personalized Medicine
Hamburg, M. A., & Collins, F. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006304 · Cited by 1,970
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Self-citationSalvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers
Idris, N. M., Gnanasammandhan, M. K., Zhang, J., Ho, P. C., Mahendran, R., & Zhang, Y. (2012) · Nature Medicine · doi:10.1038/nm.2933 · Cited by 1,464
STING: infection, inflammation and cancer.
Barber, G. N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3921 · Cited by 1,313
Barua, S., & Mitragotri, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.008 · Cited by 1,257
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Kreiter, S., Vormehr, M., van de Roemer, N., Diken, M., Löwer, M., Diekmann, J., Boegel, S., Schrörs, B., Vascotto, F., Castle, J. C., et al. (2015) · Nature · doi:10.1038/nature14426 · Cited by 1,243
Personalized medicine: Time for one-person trials
Schork, N. J. (2015) · Nature · doi:10.1038/520609a · Cited by 1,223
Tumour heterogeneity in the clinic
Bedard, P. L., Hansen, A. R., Ratain, M. J., & Siu, L. L. (2013) · Nature · doi:10.1038/nature12627 · Cited by 1,211
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Strategies to improve radiotherapy with targeted drugs
Begg, A. C., Stewart, F. A., & Vens, C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3007 · Cited by 1,118
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,101
Kircher, M. F., de la Zerda, A., Jokerst, J. V., Zavaleta, C. L., Kempen, P. J., Mittra, E., Pitter, K., Huang, R., Campos, C., Habte, F., et al. (2012) · Nature Medicine · doi:10.1038/nm.2721 · Cited by 1,064
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
Designer vaccine nanodiscs for personalized cancer immunotherapy
Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A., & Moon, J. J. (2017) · Nature Materials · doi:10.1038/nmat4822 · Cited by 1,056
Kobayashi, H., Watanabe, R., & Choyke, P. L. (2014) · Theranostics · doi:10.7150/thno.7193 · Cited by 996
Structure-based programming of lymph-node targeting in molecular vaccines
Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 943
Radiation oncology in the era of precision medicine
Baumann, M., Krause, M., Overgaard, J., Debus, J., Bentzen, S. M., Daartz, J., Richter, C., Zips, D., & Bortfeld, T. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.18 · Cited by 812
Wang, Y., Zhou, K., Huang, G., Hensley, C., Huang, X., Ma, X., Zhao, T., Sumer, B. D., DeBerardinis, R. J., & Gao, J. (2014) · Nature Materials · doi:10.1038/nmat3819 · Cited by 773
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Clinical trial of blood-brain barrier disruption by pulsed ultrasound
Carpentier, A., Canney, M., Vignot, A., Reina, V., Beccaria, K., Horodyckid, C., Karachi, C., Leclercq, D., Lafon, C., Chapelon, J.-Y., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6086 · Cited by 757
ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells
Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., van Endert, P., & Amigorena, S. (2003) · Nature · doi:10.1038/nature01911 · Cited by 753
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., & Irvine, D. J. (2010) · Nature Medicine · doi:10.1038/nm.2198 · Cited by 750
Toward understanding and exploiting tumor heterogeneity
Alizadeh, A. A., Aranda, V., Bardelli, A., Blanpain, C., Bock, C., Borowski, C., Caldas, C., Califano, A., Doherty, M., Elsner, M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3915 · Cited by 746
Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018892108 · Cited by 733
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733
Lee, C. G., Heijn, M., di Tomaso, E., Griffon, G., Ancukiewicz, M., Koike, C., Park, K. R., Ferrara, N., Jain, R. K., Suit, H. D., et al. (2000) · PubMed · Cited by 733
Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
Li, H.-J., Du, J.-Z., Du, X.-J., Xu, C.-F., Sun, C.-Y., Wang, H.-X., Cao, Z.-T., Yang, X.-Z., Zhu, Y.-H., Nie, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522080113 · Cited by 724
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
Phillips, E., Penate-Medina, O., Zanzonico, P. B., Carvajal, R. D., Mohan, P., Ye, Y., Humm, J., Gönen, M., Kalaigian, H., Schöder, H., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009524 · Cited by 712
Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents
Kim, J.-W., Galanzha, E. I., Shashkov, E. V., Moon, H.-M., & Zharov, V. P. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.231 · Cited by 710
Lin, J., Wang, S., Huang, P., Wang, Z., Chen, S., Niu, G., Li, W., He, J., Cui, D., Lu, G., et al. (2013) · ACS Nano · doi:10.1021/nn4011686 · Cited by 661
Self-citationInvestigating the optimal size of anticancer nanomedicine
Tang, L., Yang, X., Yin, Q., Cai, K., Wang, H., Chaudhury, I., Yao, C., Zhou, Q., Kwon, M., Hartman, J. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411499111 · Cited by 654
Kim, S. E., Zhang, L., Ma, K., Riegman, M., Chen, F., Ingold, I., Conrad, M., Turker, M. Z., Gao, M., Jiang, X., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.164 · Cited by 622
Developing mRNA-vaccine technologies
Schlake, T., Thess, A., Fotin-Mleczek, M., & Kallen, K.-J. (2012) · RNA Biology · doi:10.4161/rna.22269 · Cited by 622
Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D. M., Peters, A. M., Vile, R. G., & Stewart, J. S. W. (2001) · PubMed · Cited by 575
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Hamzah, J., Jugold, M., Kiessling, F., Rigby, P., Manzur, M., Marti, H. H., Rabie, T., Kaden, S., Gröne, H.-J., Hämmerling, G. J., et al. (2008) · Nature · doi:10.1038/nature06868 · Cited by 564
Materials engineering for immunomodulation
Hubbell, J. A., Thomas, S. N., & Swartz, M. A. (2009) · Nature · doi:10.1038/nature08604 · Cited by 561
Using Nanoparticles to Enable Simultaneous Radiation and Photodynamic Therapies for Cancer Treatment
Chen, W., & Zhang, J. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.327 · Cited by 560
Nanotheranostics for personalized medicine
Mura, S., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.006 · Cited by 527
Mi, P., Kokuryo, D., Cabral, H., Wu, H., Terada, Y., Saga, T., Aoki, I., Nishiyama, N., & Kataoka, K. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.72 · Cited by 512
Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model
Leinenga, G., & Götz, J. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa2512 · Cited by 498
Image-guided radiotherapy: from current concept to future perspectives
Jaffray, D. A. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.194 · Cited by 496
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
Kunjachan, S., Ehling, J., Storm, G., Kiessling, F., & Lammers, T. (2015) · Chemical Reviews · doi:10.1021/cr500314d · Cited by 480
Nanoparticle-Based Immunotherapy for Cancer
Shao, K., Singha, S., Clemente-Casares, X., Tsai, S., Yang, Y., & Santamaria, P. (2015) · ACS Nano · doi:10.1021/nn5062029 · Cited by 470
New approaches for imaging tumour responses to treatment
Brindle, K. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2289 · Cited by 460
Manzoor, A. A., Lindner, L. H., Landon, C. D., Park, J.-Y., Simnick, A. J., Dreher, M. R., Das, S., Hanna, G., Park, W., Chilkoti, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1683 · Cited by 459
Hailemichael, Y., Dai, Z., Jaffarzad, N., Ye, Y., Medina, M. A., Huang, X.-F., Dorta-Estremera, S. M., Greeley, N. R., Nitti, G., Peng, W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3105 · Cited by 457
Guo, Y., Wang, D., Song, Q., Wu, T., Zhuang, X., Bao, Y., Kong, M., Qi, Y., Tan, S., & Zhang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b01042 · Cited by 413
Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery
Matsumoto, Y., Nichols, J. W., Toh, K., Nomoto, T., Cabral, H., Miura, Y., Christie, R. J., Yamada, N., Ogura, T., Kano, M. R., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.342 · Cited by 412
Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation
Burgdorf, S., Schölz, C., Kautz, A., Tampé, R., & Kurts, C. (2008) · Nature Immunology · doi:10.1038/ni.1601 · Cited by 405
Engineering Nano‐ and Microparticles to Tune Immunity
Moon, J. J., Huang, B., & Irvine, D. J. (2012) · Advanced Materials · doi:10.1002/adma.201200446 · Cited by 404
Kotagiri, N., Sudlow, G. P., Akers, W. J., & Achilefu, S. (2015) · Nature Nanotechnology · doi:10.1038/nnano.2015.17 · Cited by 404
Nanoscintillator-Mediated X-ray Inducible Photodynamic Therapy for In Vivo Cancer Treatment
Chen, H., Wang, G. D., Chuang, Y.-J., Zhen, Z., Chen, X., Biddinger, P., Hao, Z., Liu, F., Shen, B., Pan, Z., et al. (2015) · Nano Letters · doi:10.1021/nl504044p · Cited by 381
Self-citationNanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
Hanson, M. C., Crespo, M. P., Abraham, W., Moynihan, K. D., Szeto, G. L., Chen, S. H., Melo, M. B., Mueller, S., & Irvine, D. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79915 · Cited by 381
Zhang, D., Qi, G., Zhao, Y., Qiao, S., Yang, C., & Wang, H. (2015) · Advanced Materials · doi:10.1002/adma.201502598 · Cited by 380
Miller, M. A., Gadde, S., Pfirschke, C., Engblom, C., Sprachman, M. M., Kohler, R. H., Yang, K. S., Laughney, A. M., Wojtkiewicz, G., Kamaly, N., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6522 · Cited by 347
Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
Taurin, S., Nehoff, H., & Greish, K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.013 · Cited by 309
Seymour (2009) · International Journal of Oncology · doi:10.3892/ijo_00000293 · Cited by 304
Huang, J., Li, Y., Orza, A., Lu, Q., Guo, P., Wang, L., Yang, L., & Mao, H. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201504185 · Cited by 292
An injectable nanoparticle generator enhances delivery of cancer therapeutics
Xu, R., Zhang, G., Mai, J., Deng, X., Segura-Ibarra, V., Wu, S., Shen, J., Liu, H., Hu, Z., Chen, L., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3506 · Cited by 280
Hansen, A. E., Petersen, A. L., Henriksen, J. R., Boerresen, B., Rasmussen, P., Elema, D. R., Rosenschöld, P. M. A., Kristensen, A. T., Kjær, A., & Andresen, T. L. (2015) · ACS Nano · doi:10.1021/acsnano.5b01324 · Cited by 277
Ponce, A. M., Viglianti, B. L., Yu, D., Yarmolenko, P. S., Michelich, C. R., Woo, J., Bally, M. B., & Dewhirst, M. W. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk005 · Cited by 273
(1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/67.3.663 · Cited by 268
Werner, M. E., Cummings, N. D., Sethi, M., Wang, E. C., Sukumar, R., Moore, D. T., & Wang, A. Z. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.02.009 · Cited by 267
Markedly Enhanced Permeability and Retention Effects Induced by Photo-immunotherapy of Tumors
Sano, K., Nakajima, T., Choyke, P. L., & Kobayashi, H. (2013) · ACS Nano · doi:10.1021/nn305011p · Cited by 263
Immunomodulatory spherical nucleic acids
Radovic-Moreno, A. F., Chernyak, N., Mader, C. C., Nallagatla, S., Kang, R. S., Hao, L., Walker, D. A., Halo, T. L., Merkel, T. J., Rische, C. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502850112 · Cited by 259
Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy
Koshy, S. T., Cheung, A. S., Gu, L., Graveline, A. R., & Mooney, D. J. (2017) · Advanced Biosystems · doi:10.1002/adbi.201600013 · Cited by 256
X-Ray Induced Photodynamic Therapy: A Combination of Radiotherapy and Photodynamic Therapy
Wang, G. D., Nguyen, H. T., Chen, H., Cox, P. B., Wang, L., Nagata, K., Hao, Z., Wang, A., Li, Z., & Xie, J. (2016) · Theranostics · doi:10.7150/thno.16141 · Cited by 251
Self-citationRaising the Bar: The Curative Potential of Human Cancer Immunotherapy
Rosenberg, S. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003634 · Cited by 244
Bonvalot, S., Le Pechoux, C., De Baere, T., Kantor, G., Buy, X., Stoeckle, E., Terrier, P., Sargos, P., Coindre, J. M., Lassau, N., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1297 · Cited by 243
Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
Greish, K., Nehoff, H., Parayath, N., Domanovitch, L., & Taurin, S. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s47129 · Cited by 238
Smith, B. R., Ghosn, E. E. B., Rallapalli, H., Prescher, J. A., Larson, T., Herzenberg, L. A., & Gambhir, S. S. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.62 · Cited by 237
Cancer nanomedicine: is targeting our target?
Lammers, T., Kiessling, F., Ashford, M., Hennink, W., Crommelin, D., & Storm, G. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.69 · Cited by 233
Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of Nanoparticles
Zhen, Z., Tang, W., Chuang, Y.-J., Todd, T., Zhang, W., Lin, X., Niu, G., Liu, G., Wang, L., Pan, Z., et al. (2014) · ACS Nano · doi:10.1021/nn501134q · Cited by 228
Self-citationNanotheranostics for personalized medicine
Kim, T. H., Lee, S., & Chen, X. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.13.15 · Cited by 222
Self-citationLu, W., Melancon, M. P., Xiong, C., Huang, Q., Elliott, A., Song, S., Zhang, R., Flores, L. G., Gelovani, J. G., Wang, L. V., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4557 · Cited by 205
Zhu, X., Xu, Y., Solis, L. M., Tao, W., Wang, L., Behrens, C., Xu, X., Zhao, L., Liu, D., Wu, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505629112 · Cited by 203
Interfacial geometry dictates cancer cell tumorigenicity
Lee, J., Abdeen, A. A., Wycislo, K. L., Fan, T. M., & Kilian, K. A. (2016) · Nature Materials · doi:10.1038/nmat4610 · Cited by 196
Lin, J., Wang, M., Hu, H., Yang, X., Wen, B., Wang, Z., Jacobson, O., Song, J., Zhang, G., Niu, G., et al. (2016) · Advanced Materials · doi:10.1002/adma.201505700 · Cited by 196
Self-citationKoukourakis, M. I., Koukouraki, S., Giatromanolaki, A., Archimandritis, S. C., Skarlatos, J., Beroukas, K., Bizakis, J. G., Retalis, G., Karkavitsas, N., & Helidonis, E. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3512 · Cited by 191
Kotb, S., Detappe, A., Lux, F., Appaix, F., Barbier, E. L., Tran, V.-L., Plissonneau, M., Gehan, H., Lefranc, F., Rodriguez-Lafrasse, C., et al. (2016) · Theranostics · doi:10.7150/thno.14018 · Cited by 182
mRNA-based dendritic cell vaccines
Benteyn, D., Heirman, C., Bonehill, A., Thielemans, K., & Breckpot, K. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2014.957684 · Cited by 180
Intraoperative diagnostics and elimination of residual microtumours with plasmonic nanobubbles
Lukianova-Hleb, E. Y., Kim, Y.-S., Belatsarkouski, I., Gillenwater, A. M., O'Neill, B. E., & Lapotko, D. O. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.343 · Cited by 178
Photodynamic therapy: a means to enhanced drug delivery to tumors.
Snyder, J. W., Greco, W. R., Bellnier, D. A., Vaughan, L. A., & Henderson, B. W. (2003) · PubMed · Cited by 176
Chen, B., Pogue, B. W., Luna, J. M., Hardman, R. L., Hoopes, P. J., & Hasan, T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1673 · Cited by 175
Exploring the Tumor Microenvironment with Nanoparticles
Miao, L., & Huang, L. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4_9 · Cited by 173
Tamarov, K. P., Osminkina, L. A., Zinovyev, S. V., Maximova, K. A., Kargina, J. V., Gongalsky, M. B., Ryabchikov, Y., Al-Kattan, A., Sviridov, A. P., Sentis, M., et al. (2014) · Scientific Reports · doi:10.1038/srep07034 · Cited by 171
On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles
Lukianova-Hleb, E. Y., Ren, X., Sawant, R. R., Wu, X., Torchilin, V. P., & Lapotko, D. O. (2014) · Nature Medicine · doi:10.1038/nm.3484 · Cited by 170
Tang, Y., Hu, J., Elmenoufy, A. H., & Yang, X. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b03067 · Cited by 170
A Temperature-Sensitive Liposomal 1H CEST and 19F Contrast Agent for MR Image-Guided Drug Delivery
Langereis, S., Keupp, J., van Velthoven, J. L. J., de Roos, I. H. C., Burdinski, D., Pikkemaat, J. A., & Grüll, H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8087532 · Cited by 166
Wang, D., Miller, S. C., Liu, X., Anderson, B., Wang, X., & Goldring, S. R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2106 · Cited by 159
Clinical Application of High-intensity Focused Ultrasound in Cancer Therapy
Hsiao, Y.-H., Kuo, S., Tsai, H., Chou, M., & Yeh, G. (2016) · Journal of Cancer · doi:10.7150/jca.13906 · Cited by 155
Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery
Karve, S., Werner, M. E., Sukumar, R., Cummings, N. D., Copp, J. A., Wang, E. C., Li, C., Sethi, M., Chen, R. C., Pacold, M. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120508109 · Cited by 154
Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties
Liu, R., Jiang, W., Walkey, C., Chan, W. C. W., & Cohen, Y. (2015) · Nanoscale · doi:10.1039/c5nr01537e · Cited by 154
X-ray-Induced Singlet Oxygen Activation with Nanoscintillator-Coupled Porphyrins
Bulin, A., Truillet, C., Chouikrat, R., Lux, F., Frochot, C., Amans, D., Ledoux, G., Tillement, O., Perriat, P., Barberi‐Heyob, M., et al. (2013) · The Journal of Physical Chemistry C · doi:10.1021/jp4077189 · Cited by 153
Gasselhuber, A., Dreher, M. R., Partanen, A., Yarmolenko, P., Woods, D. L., Wood, B. J., & Haemmerich, D. (2012) · International Journal of Hyperthermia · doi:10.3109/02656736.2012.677930 · Cited by 152
Kaida, S., Cabral, H., Kumagai, M., Kishimura, A., Terada, Y., Sekino, M., Aoki, I., Nishiyama, N., Tani, T., & Kataoka, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0303 · Cited by 143
Quantitative Analysis of the Enhanced Permeation and Retention (EPR) Effect
Wong, A. D., Ye, M., Ulmschneider, M. B., & Searson, P. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123461 · Cited by 137
Engineering opportunities in cancer immunotherapy
Jeanbart, L., & Swartz, M. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508516112 · Cited by 135
Mittra, E., Goris, M. L., Iagaru, A. H., Kardan, A., Burton, L., Berganos, R. A., Chang, E., Liu, S., Shen, B., Chin, F. T., et al. (2011) · Radiology · doi:10.1148/radiol.11101139 · Cited by 130
Self-citationChemodosimetry of in vivo tumor liposomal drug concentration using MRI
Viglianti, B. L., Ponce, A. M., Michelich, C. R., Yu, D., Abraham, S. A., Sanders, L. L., Yarmolenko, P., Schroeder, T., MacFall, J. R., Barboriak, D. P., et al. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21032 · Cited by 130
Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
Pérez-Medina, C., Abdel-Atti, D., Tang, J., Zhao, Y., Fayad, Z. A., Lewis, J. S., Mulder, W. J. M., & Reiner, T. (2016) · Nature Communications · doi:10.1038/ncomms11838 · Cited by 128
Evaluation of nanomedicines: stick to the basics
McNeil, S. E. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.73 · Cited by 126
Heist, R. S., Duda, D. G., Sahani, D. V., Ancukiewicz, M., Fidias, P., Sequist, L. V., Temel, J. S., Shaw, A. T., Pennell, N. A., Neal, J. W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424024112 · Cited by 126
Real-Time Monitoring of Arsenic Trioxide Release and Delivery by Activatable T1 Imaging
Zhao, Z., Wang, X., Zhang, Z., Zhang, H., Liu, H., Zhu, X., Li, H., Chi, X., Yin, Z., & Gao, J. (2015) · ACS Nano · doi:10.1021/nn506640h · Cited by 124
Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond
Mitragotri, S., Lammers, T., Bae, Y. H., Schwendeman, S. P., Smedt, S. C. D., Leroux, J., Peer, D., Kwon, I. C., Harashima, H., Kikuchi, A., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.011 · Cited by 124
Imaging approaches to optimize molecular therapies
Weissleder, R., Schwaiger, M. C., Gambhir, S. S., & Hricak, H. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf3936 · Cited by 112
Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery
Nguyen, D. N., Mahon, K. P., Chikh, G., Kim, P., Chung, H., Vicari, A. P., Love, K. T., Goldberg, M. S., Chen, S., Krieg, A. Μ., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121423109 · Cited by 110
Theek, B., Gremse, F., Kunjachan, S., Fokong, S., Pola, R., Pechar, M., Deckers, R., Storm, G., Ehling, J., Kiessling, F. M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.007 · Cited by 109
You, Y., Wang, Z., Ran, H., Zheng, Y., Wang, D., Xu, J., Wang, Z., Chen, Y., & Li, P. (2016) · Nanoscale · doi:10.1039/c5nr08292g · Cited by 109
Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching
Kaittanis, C., Shaffer, T. M., Ogirala, A., Santra, S., Perez, J. M., Chiosis, G., Li, Y., Josephson, L., & Grimm, J. (2014) · Nature Communications · doi:10.1038/ncomms4384 · Cited by 107
Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring
Perlstein, B., Ram, Z., Daniels, D., Ocherashvilli, A., Roth, Y., Margel, S., & Mardor, Y. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-002 · Cited by 101
Pogue, B. W., O’Hara, J. A., Demidenko, E., Wilmot, C. M., Goodwin, I. A., Chen, B., Swartz, H. M., & Hasan, T. G. (2003) · PubMed · Cited by 100
Activatable Molecular Probes for Cancer Imaging
Lee, S., Xie, J., & Chen, X. S. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791384270 · Cited by 99
Self-citationImaging Nanoprobe for Prediction of Outcome of Nanoparticle Chemotherapy by Using Mammography
Karathanasis, E., Suryanarayanan, S., Balusu, S. R., McNeeley, K. M., Sechopoulos, I., Karellas, A., Annapragada, A., & Bellamkonda, R. V. (2009) · Radiology · doi:10.1148/radiol.2502080801 · Cited by 97
PET–CT for radiotherapy treatment planning and response monitoring in solid tumors
Bussink, J., Kaanders, J. H. A. M., van der Graaf, W. T. A., & Oyen, W. J. G. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.218 · Cited by 96
Li, C. J., Miyamoto, Y., Kojima, Y., & Maeda, H. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.179 · Cited by 96
Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy
Detappe, A., Kunjachan, S., Sancey, L., Motto‐Ros, V., Biancur, D. E., Drané, P., Guièze, R., Makrigiorgos, G. M., Tillement, O., Langer, R., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.021 · Cited by 96
Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications
Jain, R. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2994 · Cited by 95
Kobayashi, H., Reijnders, K., English, S. J., Yordanov, A. T., Milenic, D. E., Sowers, A. L., Citrin, D. E., Krishna, M. C., Waldmann, T. A., Mitchell, J. B., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1175 · Cited by 94
Muhanna, N., Jin, C. S., Huynh, E., Chan, H. H. L., Qiu, Y., Jiang, W., Cui, L., Burgess, L., Akens, M. K., Chen, J., et al. (2015) · Theranostics · doi:10.7150/thno.13451 · Cited by 94
Nanoparticle Delivered VEGF-A siRNA Enhances Photodynamic Therapy for Head and Neck Cancer Treatment
Lecaros, R. L. G., Huang, L., Lee, T.-C., & Hsu, Y. (2015) · Molecular Therapy · doi:10.1038/mt.2015.169 · Cited by 93
Using N-of-1 Trials to Improve Patient Management and Save Costs
Scuffham, P., Nikles, J., Mitchell, G. K., Yelland, M. J., Vine, N., Poulos, C. J., Pillans, P. I., Bashford, G. M., Mar, C. D., Schlüter, P. J., et al. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1352-7 · Cited by 88
Stapleton, S., Milosevic, M., Allen, C. J., Zheng, J., Dunne, M., Yeung, I. W. T., & Jaffray, D. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081157 · Cited by 88
Gadofosveset-enhanced magnetic resonance angiography
Goyen, M. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.1 · Cited by 86
Structurally Programmed Assembly of Translation Initiation Nanoplex for Superior mRNA Delivery
Li, J., Wang, W., He, Y., Li, Y., Yan, E. Z., Zhang, K., Irvine, D. J., & Hammond, P. T. (2017) · ACS Nano · doi:10.1021/acsnano.6b08447 · Cited by 86
Challenges to effective cancer nanotheranostics
Melancon, M. P., Stafford, R. J., & Li, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.045 · Cited by 84
In Vivo Labeling of Serum Albumin for PET
Niu, G., Lang, L., Kiesewetter, D. O., Ma, Y., Sun, Z., Guo, N., Guo, J., Wu, C., & Chen, X. S. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.139642 · Cited by 83
Self-citationWu, W., Zhang, Q., Wang, J., Chen, M., Li, S., Lin, Z., & Li, J. (2014) · Polymer Chemistry · doi:10.1039/c4py00575a · Cited by 75
Strøm, H. H., Bremnes, R. M., Sundstrøm, S. H., Helbekkmo, N., Fløtten, Ø., & Aasebø, U. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.466 · Cited by 74
Wang, E. C., Min, Y., Palm, R. C., Fiordalisi, J. J., Wagner, K., Hyder, N., Cox, A. D., Caster, J. M., Tian, X., & Wang, A. Z. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.015 · Cited by 74
Molecular Magnetic Resonance Imaging of Tumor Response to Therapy
Shuhendler, A. J., Ye, D., Brewer, K., Bazalova‐Carter, M., Lee, K. H., Kempen, P. J., Wittrup, K. D., Graves, E. E., Rutt, B. K., & Rao, J. (2015) · Scientific Reports · doi:10.1038/srep14759 · Cited by 73
Pham, E., Yin, M., Peters, C. G., Lee, C. R., Brown, D., Xu, P., Man, S., Jayaraman, L., Rohde, E., Chow, A., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3435 · Cited by 73
Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize
Adams, S., Yang, H. C., Savariar, E. N., Aguilera, J. A., Crisp, J. L., Jones, K. A., Whitney, M. A., Lippman, S. M., Cohen, E. E. W., Tsien, R. Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms13019 · Cited by 72
Multimodal In Vivo Imaging Exposes the Voyage of Nanoparticles in Tumor Microcirculation
Toy, R., Hayden, E., Camann, A., Berman, Z. T., Vicente, P., Tran, E., Meyers, J. D., Pansky, J., Peiris, P. M., Wu, H., et al. (2013) · ACS Nano · doi:10.1021/nn3053439 · Cited by 69
DNA–inorganic hybrid nanovaccine for cancer immunotherapy
Zhu, G., Liu, Y., Yang, X., Kim, Y., Zhang, H., Jia, R., Liao, H.-S., Jin, A. J., Lin, J., Aronova, M. A., et al. (2016) · Nanoscale · doi:10.1039/c5nr08821f · Cited by 69
Self-citationMuhanna, N., Cui, L., Chan, H. H. L., Burgess, L., Jin, C. S., MacDonald, T. D., Huynh, E., Wang, F., Chen, J., Irish, J. C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1235 · Cited by 63
18F-FPPRGD2 and 18F-FDG PET of Response to Abraxane Therapy
Sun, X., Yan, Y., Liu, S., Cao, Q., Yang, M., Neamati, N., Shen, B., Niu, G., & Chen, X. S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.080606 · Cited by 57
Self-citationClinical Translation of an Albumin-Binding PET Radiotracer 68Ga-NEB
Zhang, J., Lang, L., Zhu, Z., Li, F., Niu, G., & Chen, X. S. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.159640 · Cited by 53
Self-citationArrieta, O. G., Medina, L. A., Estrada-Lobato, E., Ramírez-Tirado, L.-A., Mendoza-García, V. O., & de la Garza-Salazar, J. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2477-x · Cited by 52
Adjuvant‐Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination
Cheung, A. S., Koshy, S. T., Stafford, A. G., Bastings, M. M. C., & Mooney, D. J. (2016) · Small · doi:10.1002/smll.201600061 · Cited by 51
Rajora, A. K., Ravishankar, D., Osborn, H. M. I., & Greco, F. (2014) · Polymers · doi:10.3390/polym6082186 · Cited by 47
Guo, J., Guo, N., Lang, L., Kiesewetter, D. O., Xie, Q., Li, Q., Eden, H. S., Niu, G., & Chen, X. S. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.122069 · Cited by 47
Self-citationArrieta, O. G., Medina, L. A., Estrada-Lobato, E., Hernández‐Pedro, N., Villanueva‐Rodriguez, G. M., Martínez-Barrera, L. M., Macedo, E. O., López‐Rodríguez, V., Motola‐Kuba, D., & Corona-Cruz, J. F. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.44 · Cited by 46
Jin, C. S., Overchuk, M., Cui, L., Wilson, B. C., Bristow, R. G., Chen, J., & Zheng, G. (2016) · The Prostate · doi:10.1002/pros.23203 · Cited by 45
Gadofosveset-enhanced magnetic resonance angiography
Goyen, M. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1968 · Cited by 42
Wang, A. Z., Cummings, N. D., Sethi, M., Wang, E. C., Sukumar, R., Moore, D., & Werner, M. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.e13546 · Cited by 37
Onuki, Y., Jacobs, I., Artemov, D., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.008 · Cited by 35
Ullrich, R. T., Jikeli, J. F., Diedenhofen, M., Boehm‐Sturm, P., Unruh, M., Vollmar, S., & Hoehn, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019592 · Cited by 34
Improving chemoradiotherapy with nanoparticle therapeutics.
Eblan, M. J., & Wang, A. Z. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.08.04 · Cited by 31
Yin, D., Zhai, Y., Gruber, H. E., Ibañez, C. E., Robbins, J. M., Kells, A. P., Kasahara, N., Forsayeth, J., Jolly, D. J., & Bankiewicz, K. S. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.25 · Cited by 27
Cited by
Recent Progress in Ferroptosis Inducers for Cancer Therapy
Liang, C., Zhang, X., Yang, M., & Dong, X. (2019) · Advanced Materials · doi:10.1002/adma.201904197 · Cited by 1,569
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Tumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
van der Meel, R., Sulheim, E., Shi, Y., Kiessling, F., Mulder, W. J. M., & Lammers, T. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0567-y · Cited by 1,234
Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 830
Metadata
- Authors
- Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X.
- Venue
- Nature Reviews Materials
- Published
- 2017-05-09
- Volume
- 2
- Issue
- 7
- ISSN
- 2058-8437 (ISSN-L)
- OpenAlex
- W2613352698
- Cited by
- 1,102
- References
- 168
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.